5Wilson WA, Gharavi AE, Koike T, et al. International con-sensus statement on preliminary classification criteria for definite an - tiphospholipid syndrome: report of an internationalworkshop [ J ]. Ar~hrifisRheum, 1999,42 (7) : 1309.
7Derksen RH, Khamashta MA, Branch DW. Management of the obstetric antiphospholipid syndrome [ J ] . ArthritisPdleum, 2004,50(4) : 1028.
8Asherson RA, Cervera R, de Groot PG, eta. I Catastrophic an - tiphospholipid syndrome : international consensus statement on classification criteria and treatment guidelines[ J ] Lupus ,2003,12 (7) :530.
7Kuruvilla A . Warfarin in antiphospholipid antibody syndrome.Lancet, 2001,27(358) : 1461-1462.
8Jilma B, Kamath S, Lip GY. ABC of antithrombotic therapy : an -tithrombotic therapy in special circtanstances. Ⅱ -In children, thrombophilia, and miscellaneous conditions. BMJ, 2003,326: 93-96.
9Vinatier D, Dufour P, Cosson M, et al. Antiphospholipid syndrome and recurrent miscarriages. Eur J Obstet Gynecol Reprod Biol,2001,96: 37- 50.
10Triolo G, Ferrante A, Ciccia F, et al. Randomized study of subcutaneous low molecular weight heparin plus aspirin versus imravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies. Arthritis Rheum, 2003, 48: 728-731.
